SCOPUS 정보 검색 플랫폼

Volumn 56, Issue 8, 2007, Pages 1311-1322

International conference: Progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain

(7) Aptsiauri, Natalia a Cabrera, Teresa a,b Pawelec, Graham c Gouttefangeas, Cécile c Derhovanessian, Evelyna c Garrido, Federico a,b Garcia Lora, Angel a

a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES (Spain)

b UNIVERSITY OF GRANADA (Spain)

c UNIVERSITY OF TÜBINGEN (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CHEMOKINE RECEPTOR CCR7; COMPLEMENTARY DNA; CYTOKINE; DENDRITIC CELL VACCINE; DNA; DNA VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITOPE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 12; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MELANOMA VACCINE; NATURAL KILLER CELL RECEPTOR; PLACEBO; PLASMID DNA; RETINOIC ACID; RNA VACCINE; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR; TROVAX VACCINE; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VACCINIA VACCINE;

ADVANCED CANCER; ANTIGEN RECOGNITION; BLADDER CARCINOMA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER PATIENT; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONFERENCE PAPER; CYTOTOXICITY; EXPERIMENTAL MOUSE; GASTROINTESTINAL TUMOR; HOST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CANCER; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; MOLECULAR RECOGNITION; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROSTATE CANCER; SPAIN; STOMACH CANCER; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; TREATMENT OUTCOME;

ANIMALS; ANTIGENS, NEOPLASM; AUTOANTIBODIES; AUTOIMMUNITY; CANCER VACCINES; CLINICAL TRIALS; HUMANS; IMMUNOTHERAPY; KILLER CELLS, NATURAL; MICE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; TUMOR ESCAPE; VACCINATION; VACCINES, SUBUNIT;

EID: 34248567074 PISSN: 03407004 EISSN: None Source Type: Journal
DOI: 10.1007/s00262-007-0308-1 Document Type: Conference Paper

Times cited : (3)

References (12)

1
- 33646356509
- Immunosenescence, suppression and tumour progression
- Pawelec G, Koch S, Griesemann H, Rehbein A, Hahnel K, Gouttefangeas C (2006) Immunosenescence, suppression and tumour progression. Cancer Immunol Immunother 55:981-986
- (2006) Cancer Immunol Immunother , vol.55 , pp. 981-986
- Pawelec, G.¹ Koch, S.² Griesemann, H.³ Rehbein, A.⁴ Hahnel, K.⁵ Gouttefangeas, C.⁶

2
- 0027485675
- Natural history of HLA expression during tumour development
- Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL (1993) Natural history of HLA expression during tumour development. Immunol Today 14(10):491-499
- (1993) Immunol Today , vol.14 , Issue.10 , pp. 491-499
- Garrido, F.¹ Cabrera, T.² Concha, A.³ Glew, S.⁴ Ruiz-Cabello, F.⁵ Stern, P.L.⁶

3
- 0031080901
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
- Garrido F. Ruiz-Cabello F, Cabrera T, Perez-Villar JJ, Lopez-Botet M, Duggan-Keen M, Stern PL (1997) Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 18(2):89-95
- (1997) Immunol Today , vol.18 , Issue.2 , pp. 89-95
- Garrido, F.¹ Ruiz-Cabello, F.² Cabrera, T.³ Perez-Villar, J.J.⁴ Lopez-Botet, M.⁵ Duggan-Keen, M.⁶ Stern, P.L.⁷

4
- 1542267730
- The Tubingen approach: Identification, selection, and validation of tumor-associated HLA peptides for cancer therapy
- Singh-Jasuja H, Emmerich NP, Rammensee Hg (2004) The Tubingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy. Cancer Immunol Immunother 53:187-195
- (2004) Cancer Immunol Immunother , vol.53 , pp. 187-195
- Singh-Jasuja, H.¹ Emmerich, N.P.² Rammensee, H.³

5
- 33846225204
- MHC class I antigens and immune surveillance in transformed cells
- Aptsiauri N, Cabrera T, Garcia-Lora A, Lopez-Nevot MA, Ruiz-Cabello F, Garrido F (2007) MHC class I antigens and immune surveillance in transformed cells. Int Rev Cytol 256:139-189
- (2007) Int Rev Cytol , vol.256 , pp. 139-189
- Aptsiauri, N.¹ Cabrera, T.² Garcia-Lora, A.³ Lopez-Nevot, M.A.⁴ Ruiz-Cabello, F.⁵ Garrido, F.⁶

6
- 33749127585
- + T-cell function in Hodgkin lymphoma patients
- + T-cell function in Hodgkin lymphoma patients. Blood 108(7):2280-2289
- (2006) Blood , vol.108 , Issue.7 , pp. 2280-2289
- Ghandi, M.K.¹ Lambley, E.² Duraiswamy, J.³ Dua, U.⁴ Smith, C.⁵ Elliott, S.⁶ Gill, D.⁷ Marlton, P.⁸ Seymour, J.⁹ Khanna, R.¹⁰

7
- 33749122502
- + T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope
- + T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope. J Immunol 177(7):4897-4906
- (2006) J Immunol , vol.177 , Issue.7 , pp. 4897-4906
- Smith, C.¹ Cooper, L.² Burgess, M.³ Rist, M.⁴ Webb, N.⁵ Lambley, E.⁶ Tellam, J.⁷ Marlton, P.⁸ Seymour, J.F.⁹ Gandhi, M.¹⁰ Khanna, R.¹¹

8
- 33644587135
- ESTDAB: A collection of immunologically characterised melanoma cell lines and searchable databank
- Pawelec G, Marsh SG (2006) ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank. Cancer Immunol Immunother 55:623-627
- (2006) Cancer Immunol Immunother , vol.55 , pp. 623-627
- Pawelec, G.¹ Marsh, S.G.²

9
- 0036177020
- Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK
- Rees RC, Pawelec G, Muller L, Robins A (2002) Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK. Cancer Immunol Immunother 51:58-61
- (2002) Cancer Immunol Immunother , vol.51 , pp. 58-61
- Rees, R.C.¹ Pawelec, G.² Muller, L.³ Robins, A.⁴

10
- 0037605854
- Rees RC, Robins RA, Pawelec G, Muller L, Li G, Splendlove I (2003) International conference: progress in vaccination against cancer (PIVAC) 2002, Nottingham, UK. Cancer Immunol Immunother 52:403-407
- (2003) International conference: Progress in vaccination against cancer (PIVAC) 2002, Nottingham, UK. Cancer Immunol Immunother , vol.52 , pp. 403-407
- Rees, R.C.¹ Robins, R.A.² Pawelec, G.³ Muller, L.⁴ Li, G.⁵ Splendlove, I.⁶

11
- 28944433899
- Progress in vaccination against cancer 4
- Pawelec G. (2006) Progress in vaccination against cancer 4. Cancer Immunol Immunother 55:61-62
- (2006) Cancer Immunol Immunother , vol.55 , pp. 61-62
- Pawelec, G.¹

12
- 33645296813
- Cavallo F, Baxevanis CN (2006) Fifth European progress in vaccination against cancer conference, PIVAC 5. Cancer Immunol Immunother 55:884-890
- (2006) Fifth European progress in vaccination against cancer conference, PIVAC 5. Cancer Immunol Immunother , vol.55 , pp. 884-890
- Cavallo, F.¹ Baxevanis, C.N.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.